Anti-tuberculosis activity of three carbapenems, clofazimine and nitazoxanide using a novel ex vivo phenotypic drug susceptibility model of human tuberculosis

HIGHLIGHTS

  • who: Ximena Gonzalo and collaborators from the Department of Infectious Diseases, Faculty of Medicine, Imperial College, London , NN, UK Medicine, University of Southampton, Southampton , YD, UK have published the research work: Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human Tuberculosis, in the Journal: Antibiotics 2022, 11, x FOR PEER REVIEW of 20/09/2022
  • what: The aim of this work was to test the activity of several drugs against M. tuberculosis (MTB) H37Rv in a 3-D bioelectrospray system containing cells from human . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?